Further, we have demonstrated that FNA-MCT cells provided a good source of neoplastic cells to be used to assess the biology of MCT cells, as shown in CD117-ICC and mutation evaluation by PCR. This evidence concerns the gene KIT and intrahepatic cholangiocarcinoma.